Profusa, Inc. — Investor Relations & Filings

Profusa, Inc. is a digital health and medical technology company that develops tissue-integrating biosensors for continuous monitoring of body chemistries. The company's core technology consists of highly miniaturized, injectable sensors designed to minimize the foreign body response, enabling long-term, real-time transmission of clinical-grade data. Its primary product, the Lumee™ Oxygen Platform, is a wireless system that continuously measures tissue oxygen levels. Profusa's solutions are aimed at advancing personalized medicine, telehealth, and remote patient monitoring for conditions such as chronic limb-threatening ischemia. The company's mission is to make the body's chemistry easily accessible to improve health and wellness.